Improving Nutrition and Physical Activity for Cancer Survivors (Tools To Be Fit)
Launched by UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · Sep 14, 2021
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, called "Tools To Be Fit," is exploring how different support tools can help cancer survivors improve their nutrition, physical activity, and overall health after treatment. Research suggests that following the American Cancer Society's guidelines for nutrition and exercise can lead to better health outcomes for those who have had cancer. The study will involve participants using various tools to help them adopt healthier habits, which may contribute to a longer disease-free life.
To be eligible for this study, participants need to be at least 18 years old and have a diagnosis of certain cancers, including bladder, breast, colon, and others. They should have completed their cancer treatments and own a smartphone capable of receiving text messages. Participants will receive support throughout the study, which lasts 48 weeks, and they will engage in health coaching and complete surveys to track their progress. This trial aims to empower cancer survivors to take charge of their health and make positive lifestyle changes.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- INCLUSION CRITERIA FOR CANCER SURVIVORS:
- • 1. \>= 18 years of age.
- • 2. Diagnosis of bladder, breast, colon, endometrial, kidney (renal cell carcinoma), ovarian, prostate, or rectal cancer.
- • 3. Completed all cytotoxic chemotherapy, immunotherapy, targeted therapies, or radiation (if indicated) prior to enrollment. Hormonal treatments are allowed.
- • 4. Owns a smart phone that has access to the Internet and can receive daily text messages.
- • 5. Able to speak and read English or Spanish
- • 6. Have a support person \>= 18 years of age who speaks English or Spanish and is willing to provide informed consent and support the participant throughout the study.
- • 7. \>= 4 weeks since a major surgery to start of intervention (removal of port or catheter (cath) is not major surgery; reversal of ostomy is major surgery and will require at least 4 weeks prior to enrollment).
- • 8. Readiness, as determined by the Physical Activity Readiness Questionnaire (PAR-Q). If there are any indications that home-based exercise might be unsafe based on PAR-Q, the patient will not be enrolled until confirmation from the patient's provider is received via email and/or phone that they are safe to exercise. Providers do not need to be contacted if patients answer 'yes' to 'Is your doctor currently prescribing any medication for your blood pressure or for a heart condition?
- INCLUSION CRITERIA FOR SUPPORT PERSONS:
- • 1. Identified by a cancer survivor participant who has consented to participate in Tools To Be Fit as their support person.
- • 2. 18 years of age or older.
- • 3. Speaks and reads English or Spanish.
- • 4. Consents to complete two online surveys and four 1-on-1 health coaching calls during the 48 week study.
- Exclusion Criteria:
- EXCLUSION CRITERIA FOR CANCER SURVIVORS:
- • 1. People with potential contraindications to home-based exercise based on the PAR-Q for whom the investigator is unable to obtain physician clearance.
- • 2. ACS guideline score of \> 4 out of 6 at enrollment based on self-reported diet, BMI, and physical activity. Our screening survey will ask participants to report their height and weight; usual intake of foods in the ACS guidelines (e.g., red and processed meat, fruits, vegetables, grains); and the Godin Leisure Time Exercise Survey.
- • 3. Used a physical activity tracker and a diet tracking app for \>= 1 week in the past 3 months; these are components of our digital health tool kit.
- • 4. Planned major surgery during the study period (removal of port or cath or dermatological procedures excluded)
- • 5. Scheduled to receive any form of cancer therapy during the study period with the exception of hormonal treatments, which are allowed.
- • 6. History of severe cardiovascular, respiratory or musculoskeletal disease or joint problems that preclude moderate physical activity. Examples include unstable angina, recent myocardial infarction, oxygen-dependent pulmonary disease, and osteoarthritis requiring imminent joint replacement. Moderate arthritis that does not preclude physical activity is not a reason for ineligibility.
- • 7. History of psychiatric disorders that would preclude participation in the study intervention (e.g., untreated major depression or psychosis, substance abuse, severe personality disorder) or prevent the patient from giving informed consent.
- • 8. Participating in another weight loss, physical activity or dietary intervention clinical trial. Co-enrollment in some trials involving pharmacologic therapy is allowed. Participants are also allowed to pursue weight loss and physical activity programs on their own, as long as these programs are not provided as part of a clinical trial.
- • 9. Currently pregnant or trying to become pregnant during the study period.
- • 10. Living outside the United States during screening and/or the 48-week study period.
- EXCLUSION CRITERIA FOR SUPPORT PERSONS:
- • 1. None.
About University Of California, San Francisco
The University of California, San Francisco (UCSF) is a leading academic institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a focus on translating scientific discoveries into effective therapies, UCSF collaborates with a diverse array of stakeholders, including healthcare professionals, industry partners, and patient communities. The university's research programs emphasize interdisciplinary approaches and leverage cutting-edge technology to address complex medical challenges. As a sponsor of clinical trials, UCSF is dedicated to maintaining the highest standards of ethical conduct and scientific rigor, ensuring the safety and well-being of participants while contributing to the broader medical knowledge base.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Boston, Massachusetts, United States
San Francisco, California, United States
Patients applied
Trial Officials
Erin Van Blarigan, ScD
Principal Investigator
University of California, San Francisco
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials